Synapsoft logo
AI Insights from Disclosures
Searching...
HUMASIS CO., LTD. 205470
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
In its POCT segment, since its founding in 2000, HUMASIS CO., LTD. has researched, developed, and produced POCT immunoassay reagent product lines, new materials, and new markers within the in-vitro diagnostics field. Research and development for point-of-care diagnostic devices is proceeding toward miniaturization based on MEMS and nanotechnology, and since point-of-care diagnostic devices are used directly by non-experts, R&D is also directed toward simplifying the usage steps and automating the entire process.
Representative Director Park Uram
Founded August 29, 2014
Corporation Type KOSDAQ
Industry Classification Manufacture of medical supplies and related other medicaments
Corporate number 11011-5503308
Business number 107-88-27778
Phone Number 031-8085-6200
Fax Number 031-8085-6219
Website www.humasis.com
Company Address 37 Gunpocheomdansaneop 2-ro, Gunpo-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant